brokers' calls

Wilmar showing signs of mending profitability, analysts keep “buy” - THE EDGE SINGAPORE

Broker's Calls

Wilmar showing signs of mending profitability, analysts keep 'buy'

Wilmar’s FY2024 earnings could recover from the low level expected this year, mainly on the trend of improving sales volume.

Broker's Calls

JP Morgan upgrades TDCX to 'overweight' with lower TP of US$7.40

In contrast to market expectations, JP Morgan analysts continue to anticipate earnings growth for TDCX.
CICT garners mixed results from analysts following 3QFY2023 update; RHB upgrades to ‘buy’ - THE EDGE SINGAPORE

Broker's Calls

CICT garners mixed results from analysts following 3QFY2023 update; RHB upgrades to ‘buy’

CapitaLand Integrate Commercial Trust has garnered mixed results from analysts following its Q3FY2023 update.
Opportune time to accumulate high-quality Singapore blue chips: OCBC - THE EDGE SINGAPORE

Broker's Calls

Opportune time to accumulate high-quality Singapore blue chips: OCBC

Singapore banks’ high dividend yields will provide price support.

Broker's Calls

RHB keeps ‘buy’ on ST Engineering as it sees its share price outperformance continuing

Investors in ST Engineering can look forward to four cents of dividends every quarter, adds analyst Shekhar Jaiswal.
Driver commissions for CDG drivers remain competitive, DBS maintains 'buy' - THE EDGE SINGAPORE

Broker's Calls

Driver commissions for CDG drivers remain competitive, DBS maintains 'buy'

Gojek’s newly-announced commission cutting move is likely an attempt to attract drivers into its platform amid supply crunch.
Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma - THE EDGE SINGAPORE

Broker's Calls

Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma

Although the incremental net profit contribution is likely negligible near term, the deal presents cross-selling opportunities.
Lady luck shall return, analysts keep 'buy' on Genting Singapore - THE EDGE SINGAPORE

Broker's Calls

Lady luck shall return, analysts keep 'buy' on Genting Singapore

UOBKH analyst believes Genting Singapore would deliver sequentially higher earnings q-o-q compared to MBS in 3QFY2023.
×